Studying biomarkers in people with lung, head and neck, or airway cancers
Studies sputum and tissue samples to look for biomarkers linked to cancer in adults.
Key facts
- Who runs it
- University of Colorado, Denver
- Where
- Aurora, United StatesSee the site
- Trial code
- Registry title
- Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- Status
- Recruiting
- People taking part
- 700 people, planned
- Started
- 3 May 2001
- Expected to end
- 30 Oct 2028
- Type of study
- Observational
- Treatments tested
- immunohistochemistry staining method
- laboratory biomarker analysis
- sputum cytology
- biopsy
- Record updated
- 3 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with moderate or severe dysplasia of the airway lining, or with lung, head and neck, or aerodigestive cancer, plus people without dysplasia who need a bronchoscopy for other reasons.
- Age
- 21 to 90 years
- Sex
- Men and women
- Disease stage
- Moderate or severe dysplasia of the respiratory lining, or lung, head and neck, or aerodigestive tract cancer, including fully resected Stage I non-small cell lung cancer. A group without dysplasia is also included.
- Earlier treatment
- Some people have had a bronchogenic carcinoma resected or lived one year or more after an aerodigestive cancer. Others have had previous high-grade dysplasia or worse and need a repeat bronchoscopy to monitor treatment response.
Main reasons for not taking part
- Clear signs of a bleeding disorder
- Life-threatening heart rhythm problem
- Oxygen saturation under 90% with extra oxygen before bronchoscopy
- Active coronary artery disease, including a heart attack within 6 weeks, or poorly controlled heart failure
- Acute bronchitis or pneumonia within 8 weeks
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Two broad patient groups are of interest: those with extensive and severe dysplasia of the respiratory epithelium and those without dysplasia of the respiratory epithelium. The patients with dysplasia will be recruited from the following:
- Individuals identified through the SPORE Tissue Procurement Screening Project with moderate or severe dysplasia
- Patients identified by private and academic physicians with moderate or severe dysplasia on cytology
- One year or greater survivors of one or more aerodigestive system carcinomas
- Patients with head and neck cancers who are undergoing routine panendoscopy
- Patients undergoing resection of a bronchogenic carcinoma
- Fully resected Stage I non-small cell cancer patients
- Patient's undergoing bronchoscopy for diagnosis or staging of suspected lung cancer
- Subjects with previous high-grade dysplasia or worse undergoing subsequent bronchoscopy for surveillance or monitoring of response to endobronchial treatment
- Patients suspected of or at risk for neoplastic lung disease who are undergoing a bronchoscopy in which differential diagnostic considerations may include multiple other etiologies such as infection and other processes
- Patients without dysplasia will be: patients undergoing clinically indicated bronchoscopy for conditions other than suspected lung cancer
Who cannot take part
- Hypoxemia (less than 90% saturation with supplemental oxygen) prior to bronchoscopy
- Patients are not eligible if any one of the following conditions exist:
- Clinically apparent bleeding diathesis
- Cardiac dysrhythmia that is potentially life threatening, such as ventricular tachycardia, multifocal premature ventricular contractions or supraventricular tachycardias with a rapid ventricular response. Well-controlled atrial fibrillation or rare (< 2/minute) premature ventricular contractions are not exclusionary
- Evidence of clinically active coronary artery disease, including myocardial infarction within 6 weeks, anginal chest pain, or poorly controlled congestive heart failure, or any other serious medical condition which would preclude a patient from undergoing a bronchoscopy
- Acute bronchitis or pneumonia within 8 weeks, except if these are considered clinically to be possibly a result of lung cancer
- Inability to give informed consent
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 90 years old?
Where in United States
- University of Colorado Cancer Center at UC Health Sciences CenterAurora, United StatesContact: Clinical Trials Office - University of Colorado Cancer CenterTaking people
About the trial
What the trial wants to find out
RATIONALE: Studying samples of sputum and tissue in the laboratory from patients with dysplasia or cancer may help doctors identify and learn more about biomarkers related to cancer. It may also help the study of cancer in the future.
Read full original descriptionShow less
PURPOSE: This laboratory study is looking at biomarkers in patients with respiratory tract dysplasia or lung cancer, head and neck cancer, or aerodigestive tract cancer.
Treatments tested
- immunohistochemistry staining method
- laboratory biomarker analysis
- sputum cytology
- biopsy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Biomarkers and Dysplastic Respiratory Epithelium
- Plain-language title
- Studying biomarkers in people with lung, head and neck, or airway cancersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Criteria questions
- Built from NCT00900419, who can take part
- Record updated
- 3 November 2026